Ultrasound-Targeted Microbubble Destruction-Mediated miR-1228 Downregulation Suppresses Tumor Proliferation, Migration, and Invasion of Cervical-Cancer Cells

Objectives: Ultrasound-targeted microbubble destruction (UTMD) is an effective technology for microRNA (miRNA) delivery. miR-1228 plays a crucial role and acts as an oncogenic role in several types of cancers. This study aimed to investigate the functional effect of UTMD-mediated miR-1228 knockdown in cervical-cancer cells. Design: A total of 131 patients who were diagnosed with cervical cancer by histopathological examination were enrolled in this study at the Third Affiliated Hospital of Qiqihar Medical University from February 2018 to January 2021. Participants/Materials, Setting, Methods: miR-1228 expression was tested by reverse-transcription quantitative PCR assay. miR-1228 inhibitors were transfected into cervical-cancer cells using the UTMD method. Then, Cell Counting Kit-8 and transwell assays were carried out to explore the cell proliferation, migration, and invasion potentials, respectively. Results: The results revealed that miR-1228 expression was high in human cervical-cancer tissues and cell lines. Knockdown of miR-1228 suppressed tumor cell proliferation abilities, migration, and invasion capacities. Moreover, UTMD-mediated mIR-1228 inhibitor delivery enhanced the transfection efficiency of miR-1228 inhibitor alone. The UTMD-mediated miR-1228 inhibition enhanced the suppressive role of miR-1228 downregulation on cell proliferation capacity, migration, and invasion abilities in tumor cells, compared to miR-1228 knockdown alone. Limitations: The experiments were carried out only in SiHa and HeLa cells in vitro, and the results were not verified in animals. Conclusions: These results indicated that the delivery of the UTMD-mediated miR-1228 inhibitor might be a potential therapeutic method for the treatment of cervical cancer through suppressing cellular activities.

[1]  Hong Wang,et al.  Identification of miR-885-5p as a Tumor Biomarker: Regulation of Cellular Function in Cervical Cancer , 2021, Gynecologic and Obstetric Investigation.

[2]  J. Schalken,et al.  Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer , 2021, World Journal of Urology.

[3]  W. Zhuang,et al.  hsa-miR-33-5p as a Therapeutic Target Promotes Apoptosis of Breast Cancer Cells via Selenoprotein T , 2021, Frontiers in Medicine.

[4]  Mohammad Saeed Rad,et al.  Using Dynamic Features for Automatic Cervical Precancer Detection , 2021, Diagnostics.

[5]  J. Liu,et al.  A Novel Tumor Suppressor ASMTL-AS1 Regulates the Mir-1228-3p/SOX17/Β-Catenin Axis in Triple-Negative Breast Cancer , 2021 .

[6]  Shengli Zhao,et al.  Ultrasound-Targeted Microbubble Destruction Enhances the Inhibitive Efficacy of miR-21 Silencing in HeLa Cells , 2020, Medical science monitor : international medical journal of experimental and clinical research.

[7]  A. Jemal,et al.  Cancer statistics for adolescents and young adults, 2020 , 2020, CA: a cancer journal for clinicians.

[8]  Rui Li,et al.  Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis , 2020, BioMed research international.

[9]  A. Lutz,et al.  Ultrasound and microbubble mediated therapeutic delivery: Underlying mechanisms and future outlook. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Ling Zhang,et al.  MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway , 2020, World Journal of Surgical Oncology.

[11]  Xiaohua Li,et al.  Ultrasound-targeted microbubble destruction-mediated miR-767 inhibition suppresses tumor progression of non-small cell lung cancer. , 2020, Experimental and therapeutic medicine.

[12]  Z. G. Wang,et al.  Ultrasound-Mediated Long-Circulating Nanopolymer Delivery of Therapeutic siRNA and Antisense MicroRNAs Leads to Enhanced Paclitaxel Sensitivity in Epithelial Ovarian Cancer Chemotherapy. , 2020, ACS biomaterials science & engineering.

[13]  Yun Xu,et al.  Ultrasound-Mediated Co-Delivery of miR-34a and sPD-1 Complexed with Microbubbles for Synergistic Cancer Therapy , 2020, Cancer management and research.

[14]  Dongdong Zhang,et al.  MiR-520d-5p functions as a tumor-suppressor gene in cervical cancer through targeting PTK2. , 2020, Life sciences.

[15]  Jianguo Song,et al.  CircRNA_100395 inhibits cell proliferation and metastasis in ovarian cancer via regulating miR-1228/p53/epithelial-mesenchymal transition (EMT) axis , 2020, Journal of Cancer.

[16]  Jacques Ferlay,et al.  Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis , 2019, The Lancet. Global health.

[17]  Binghui Kong,et al.  MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5. , 2019, European review for medical and pharmacological sciences.

[18]  Yu Wang,et al.  Biosynthetic nanobubbles for targeted gene delivery by focused ultrasound. , 2019, Nanoscale.

[19]  A. Akbari,et al.  Deregulation of miR-21 and miR-29a in Cervical Cancer Related to HPV Infection. , 2019, MicroRNA.

[20]  Manojit Pramanik,et al.  Combined ultrasound and photoacoustic imaging of blood clot during microbubble-assisted sonothrombolysis , 2019, Journal of biomedical optics.

[21]  Yunfeng Zhou,et al.  MiR-34b regulates cervical cancer cell proliferation and apoptosis , 2019, Artificial cells, nanomedicine, and biotechnology.

[22]  Y. Ma,et al.  Synergistic anti-tumor effect of paclitaxel and miR-34a combined with ultrasound microbubbles on cervical cancer in vivo and in vitro , 2019, Clinical and Translational Oncology.

[23]  K. Saliminejad,et al.  An overview of microRNAs: Biology, functions, therapeutics, and analysis methods , 2018, Journal of cellular physiology.

[24]  Daishi Chen,et al.  CircRNA hsa_circ_100395 regulates miR-1228/TCF21 pathway to inhibit lung cancer progression , 2018, Cell cycle.

[25]  A. Naccarati,et al.  MicroRNAs as markers of progression in cervical cancer: a systematic review , 2018, BMC Cancer.

[26]  J. Escoffre,et al.  Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring , 2017, Expert opinion on drug delivery.

[27]  Jiamin Chen,et al.  microRNA‐1228* impairs the pro‐angiogenic activity of gastric cancer cells by targeting macrophage migration inhibitory factor , 2017, Life sciences.

[28]  R. Chen,et al.  MicroRNA-1228* inhibit apoptosis in A549 cells exposed to fine particulate matter , 2016, Environmental Science and Pollution Research.

[29]  P. Claudio,et al.  Ultrasound-mediated oncolytic virus delivery and uptake for increased therapeutic efficacy: state of art , 2015, Oncolytic virotherapy.

[30]  Ming Liu,et al.  MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein. , 2015, International journal of clinical and experimental pathology.

[31]  S. Li,et al.  miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop , 2014, British Journal of Cancer.

[32]  Zhi-Yi Chen,et al.  New development and application of ultrasound targeted microbubble destruction in gene therapy and drug delivery. , 2013, Current gene therapy.

[33]  Jia Wu,et al.  Restoration of miR-1228* Expression Suppresses Epithelial-Mesenchymal Transition in Gastric Cancer , 2013, PloS one.

[34]  M. V. van Zandvoort,et al.  Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[35]  B. Yan,et al.  miR-1228 prevents cellular apoptosis through targeting of MOAP1 protein , 2012, Apoptosis.

[36]  D. Stewart,et al.  Therapeutic Arteriogenesis by Ultrasound-Mediated VEGF165 Plasmid Gene Delivery to Chronically Ischemic Skeletal Muscle , 2007, Circulation research.

[37]  Yuping Wang,et al.  Advances in the techniques and methodologies of cancer gene therapy. , 2019, Discovery medicine.

[38]  Hugo A Katus,et al.  Ultrasound targeted microbubble destruction for drug and gene delivery. , 2008, Expert opinion on drug delivery.